International Latino Research Partnership
ILRP
2 other identifiers
interventional
360
2 countries
3
Brief Summary
Through a grant funded by the National Institute on Drug Abuse (NIDA) the Center for Multicultural Mental Health Research at Cambridge Health Alliance is testing a screening and intervention project designed to improve the quality of care for Latino patients with comorbid mental health and substance use problems. We will first test a screening of comorbid problems with patients identified in mental health as well as primary health care. Building on that work, we will test the feasibility, acceptability and efficacy of the "Integrated Intervention for Dual Problems and Early Action" (IIDEA) intervention addressing mental health, substance use, and prevention of HIV, as well as a smoking cessation supplement. The project is being conducted in Massachusetts as well as at two sites in Spain. As such, the proposed ILRP multi-site international project is a critical step towards developing models of integrated care for the large and diverse Latino migrant population and more broadly towards understanding how best to integrate evidence-based assessment and treatments for co-occurring substance and mental health problems and HIV risks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2014
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2014
CompletedFirst Posted
Study publicly available on registry
January 17, 2014
CompletedStudy Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2017
CompletedMay 1, 2017
April 1, 2017
2.9 years
January 14, 2014
April 27, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Addiction Severity Index (ASI) - Alcohol (change)
The ASI is a semi-structured interview designed to address seven potential problem areas in substance-abusing patients; this outcome measure refers to the Alcohol problem area.
Baseline, 2 months, 4 months, 6 months, 12 months
Addiction Severity Index (ASI) - Drugs (change)
The ASI is a semi-structured interview designed to address seven potential problem areas in substance-abusing patients; this outcome measure refers to the Drug problem area.
Baseline, 2 months, 4 months, 6 months, 12 months
Change on Urine Drug Test (change)
Technical analysis of a biological specimen (urine) to determine the presence or absence of specified parent drugs or their metabolites.
Baseline, 2 months, 4 months, 6 months, 12 months
Secondary Outcomes (4)
Generalized Anxiety Disorder 7-item (GAD-7) Scale (change)
Baseline, 2 months, 4 months, 6 months, 12 months
PTSD Checklist for DSM-V (PCL-5)
Baseline, 2 months, 4 months, 6 months, 12 months
Patient Health Questionnaire (PHQ-9) (change)
Baseline, 2 months, 4 months, 6 months, 12 months
Hopkins Symptom Checklist-20
Baseline, 2 months, 4 months, 6 months, 12 months
Study Arms (2)
IIDEA
ACTIVE COMPARATORPatients in the Integrated Intervention for Dual Problems and Early Action (IIDEA) arm will receive the 10 session intervention administered in person and via telephone.
Usual Care
NO INTERVENTIONPatients in this arm receive usual care for dual-diagnosis symptoms of mental health and substance use. They receive 5 check-in calls from a care manager to assess safety.
Interventions
Integrated Intervention for Dual Problems and Early Action (IIDEA) includes psycho-education, Cognitive Behavioral Therapy and mindfulness; identifies triggers and challenging thoughts; provides motivational techniques for reducing substance use and/or smoking cravings; incorporates cognitive restructuring to identify and correct negative thinking patterns influenced by depression, anxiety and/or trauma; and includes self-monitoring of thoughts and risk behaviors that contribute to substance use, smoking and increased HIV risk.
Eligibility Criteria
You may qualify if:
- Latino migrants
- Must speak English or Spanish
- years of age
- Screen positive to at least one substance use and one mental health problem
You may not qualify if:
- Current or recent (last 3 months) substance use treatment (more than 1 visit with a provider at a behavioral health clinic)
- Planning to receive behavioral health services (i.e., have an appointment scheduled in the next 2 months)
- Evidence that the patient lacks capacity to consent to the study
- Evidence of current suicidal risk or harm to others (affirmative responses to questions 4 and/or 5 on Paykel suicide questionnaire)- patient can be rescreened in 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- Hospital Vall d'Hebroncollaborator
- Universidad Autonoma de Madridcollaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (3)
Cambridge Health Alliance
Somerville, Massachusetts, 02143, United States
Vall d'Hebron University Hospital
Barcelona, Catalonia, Spain
Universidad Autonoma de Madrid Medical School
Madrid, Spain
Related Publications (2)
Levison JH, Alegria M, Wang Y, Markle SL, Fuentes L, Mejia DL, Tarbox A, Albarracin Garcia L, Cellerino L, El-Bassel N. High HIV/STI Test Acceptance Through a Behavioral Health Encounter in Latino Immigrants with Substance Use and Mental Health Problems. AIDS Behav. 2019 Apr;23(4):835-846. doi: 10.1007/s10461-019-02413-y.
PMID: 30737609DERIVEDAlegria M, Falgas-Bague I, Collazos F, Carmona Camacho R, Lapatin Markle S, Wang Y, Baca-Garcia E, Le Cook B, Chavez LM, Fortuna L, Herrera L, Qureshi A, Ramos Z, Gonzalez C, Aroca P, Albarracin Garcia L, Cellerino L, Villar A, Ali N, Mueser KT, Shrout PE. Evaluation of the Integrated Intervention for Dual Problems and Early Action Among Latino Immigrants With Co-occurring Mental Health and Substance Misuse Symptoms: A Randomized Clinical Trial. JAMA Netw Open. 2019 Jan 4;2(1):e186927. doi: 10.1001/jamanetworkopen.2018.6927.
PMID: 30646205DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margarita Alegria, Ph.D.
CMMHR, Cambridge Health Alliance and Harvard Medical School
- PRINCIPAL INVESTIGATOR
Enrique Baca-Garcia, Ph.D.
Universidad Autonoma de Madrid
- PRINCIPAL INVESTIGATOR
Francisco Collazos, MD
Vall d'Hebron University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Disparities Research Unit
Study Record Dates
First Submitted
January 14, 2014
First Posted
January 17, 2014
Study Start
April 1, 2014
Primary Completion
February 28, 2017
Study Completion
February 28, 2017
Last Updated
May 1, 2017
Record last verified: 2017-04